Background Image
Table of Contents Table of Contents
Previous Page  25 / 62 Next Page
Information
Show Menu
Previous Page 25 / 62 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 31, No 1, January/February 2020

AFRICA

23

Results

Seventy patients with acute PE were evaluated and 34 (48.6%)

were male. Mean age was 43 ± 15 years. Five patients (14.3%) were

haemodynamically unstable at admission. Patient characteristics

are shown in Table 1.

Localisation of emboli was central in 40 patients (57.14%),

lobar in 18 (25.71%) and distal in 12 patients (17.14%). Saddle

emboli were observed in eight patients (11.42%).

The median clot volume measured in all patients was 4 285

mm

3

(1 650–11 226) (minimum – maximum). No correlation

was found between clot volume and age (

p

=

0.24) or gender (

p

=

0.86). Bivariate analysis using the Kruskal–Wallis test showed

that there were significant associations between clot volume

and the presence of auto-immune disease (

p

=

0.028) and

hypotension (

p

=

0.002).

Regarding pulmonary CTA parameters, a significant

correlation was found between clot volume and the following

parameters of RV dysfunction: RV diameter (

p

<

0.001), RV/LV

ratio (

p

=

0.01), PA diameter (

p

=

0.01), PA/AO ratio (

p

=

0.04)

and superior vena cava diameter (

p

=

0.01) (Table 2).

On other hand, regarding echocardiography, there was no

significant correlation found between clot volume and the

following echocardiographic parameters of RV function: TAPSE

(

p

=

0.091), S wave (

p

=

0.667), Tei index (

p

=

0.985), pulmonary

artery systolic pressure (

p

=

0.173) and RV diameter (

p

=

0.231)

(Table 2).

Discussion

PE is associated with a high risk of morbidity and mortality,

mainly resulting from RV dysfunction. The effect of PE

on RV function can be evaluated by either transthoracic

echocardiography or pulmonary CTA.

10

Echocardiography is

less costly than the other techniques available and remains

the first-line examination technique for the RV. However, RV

evaluation through echocardiography remains difficult because

of the complex anatomy of the RV, its retrosternal position,

and the interposition of the lungs.

11

In addition, studies

comparing severity of clot load with RV burden assessed by

echocardiography have reported controversial results.

10

Pulmonary CTA, on the other hand, is the method of

choice for the diagnosis of PE. It can also identify signs

of RV dysfunction that may have prognostic significance or

implications for treatment, for example, need for the institution

of thrombolytic therapy versus conventional anticoagulation

alone. Therefore there has been interest in inferring measures of

RV dysfunction from pulmonary CTA.

12

The results of our study showed a good correlation between

clot burden and signs of RV dysfunction assessed by pulmonary

CTA, but did not demonstrate a good correlation with those

commonly used signs assessed by echocardiography. Different

echocardiographic and CTA parameters of RV dysfunction

were used in previous studies to assess its correlation with clot

burden. Rodrigues

et al.

10

assessed the effect of pulmonary

vascular obstruction severity on RV function in patients with

acute PE and concluded that no significant correlation was

found between clot burden and echocardiographic parameters.

These results could support our finding despite the fact that they

used quantitative parameters such as fractional area change and

pulmonary systolic pressure.

On the hand, another study was performed by Rodrigues

et

al.

13

to evaluate the correlation between a score of angiographic

embolic load (Qanadli score, QS) and the parameters of RV

dysfunction. They found that a QS > 18 points proved to be an

independent predictor of RV dysfunction in acute PE, where

echocardiography showed higher pulmonary artery systolic

Table 1. Characteristics of the study population

Characteristic

Value

Gender

Male,

n

(%)

34 (48.6)

Female,

n

(%)

36 (51.4)

Age (mean ± SD) years

43 ± 15

Risk factors

Cancer,

n

(%)

20 (28.5)

Orthopedic surgery,

n

(%)

10 (14.28)

Auto-immune disease,

n

(%)

18 (25.7)

Heart failure,

n

(%)

8 (11.4)

Postpartum,

n

(%)

8 (11.4)

Immobilisation,

n

(%)

6 (8.5)

Table 2. Correlation between clot volume and different

imaging parameters

Parameters

Mean

SD

Correlation

coefficient

(rho)

p-

value

CT angiography

RV diameter (mm)

33.8603

6.26018

0.417

<

0.001

RV/LV

0.9331

0.18969

0.304

0.011

PA diameter (mm)

28.4651

5.30013

0.297

0.013

PA/AO

0.9023

0.16398

0.245

0.041

SVC diameter (mm)

18.3343

4.01406

0.287

0.016

Echocardiography

TAPSE

1.9355

0.45778 –0.258

0.091

S wave

9.3790

1.93405 –0.068

0.667

Tei index

0.3875

0.23753

0.003

0.985

PASP

34.3471

16.31748

0.239

0.173

RV diameter

4.6875

0.86922

0.317

0.231

SD: standard deviation, RV diameter: right ventricular diameter, RV/LV: right

ventricular/left ventricular ratio, PA diameter: pulmonary artery diameter, PA/

AO: pulmonary artery/aorta ratio, SVC diameter: superior vena cava diameter,

TAPSE: tricuspid annular plane systolic excursion, S wave: tissue Doppler

imaging (TDI)-derived tricuspid lateral annular systolic velocity, Tei index: RV

myocardial performance index, PASP: pulmonary artery systolic pressure.

Fig. 4.

Echocardiographic measurement of Tei index.